Results 61 to 70 of about 12,013 (243)

Trimetazidine Improves Mitochondrial Dysfunction in SOD1G93A Cellular Models of Amyotrophic Lateral Sclerosis through Autophagy Activation

open access: yesInternational Journal of Molecular Sciences
Amyotrophic Lateral Sclerosis (ALS) is considered the prototype of motor neuron disease, characterized by motor neuron loss and muscle waste. A well-established pathogenic hallmark of ALS is mitochondrial failure, leading to bioenergetic deficits. So far,
I. Salvatori   +17 more
semanticscholar   +1 more source

Trimetazidine as a modifier of doxorubicin+cyclophosphamideinduced hyperdyslipidemia

open access: yesThe Siberian Journal of Clinical and Experimental Medicine, 2022
Aim. The present work aimed at studying the proatherogenic potential of doxorubicin-cyclophosphamide (AC) chemotherapy regimen while simultaneously substantiating the use of trimetazidine as a modifier of the changes induced.Material and Methods.
A. Avagimyan, L. V. Kakturskiy
semanticscholar   +1 more source

Improving Postdischarge Outcomes in Acute Heart Failure [PDF]

open access: yes, 2018
The global burden that acute heart failure (AHF) carries has remained unchanged over the past several decades (1). European registries (2–5) showed that 1-year outcome rates remain unacceptably high (Table 1) and confirm that hospitalization for AHF ...
Ambrosy, Andrew P.   +8 more
core   +1 more source

Pleiotropic effects of trimetazidine

open access: yesРоссийский кардиологический журнал, 2013
Aim. To investigate potential pleiotropic effects of trimetazidine (PreductalMB) in patients with stable effort angina. Material and methods. This randomised controlled clinical study included 95 patients with Functional Class I–III stable effort angina ...
O. V. Romashchenko   +3 more
doaj   +1 more source

Evaluation of the Efficacy and Safety of Chinese Herbal Injection Combined With Trimetazidine for Viral Myocarditis: A Network Meta-Analysis

open access: yesFrontiers in Pharmacology, 2021
Background: Viral myocarditis (VMC) is a common emergency of cardiovascular disease. Current treatment for VMC includes the prohibition of exercise plus supportive and symptomatic treatment, given the lack of specific antiviral therapeutic options and ...
Kerui Wu   +7 more
doaj   +1 more source

Pharmacological screening of substances with cardioprotective effect in the group of 3-oxypyridine derivatives [PDF]

open access: yes, 2018
Research objectives: To study the anti-hypoxic and cardioprotective effects of 3-oxypyridine derivatives. The search for compounds with an antihypoxic effect was carried out on blood leukocytes of rats in in ...
Danilenko, Lyudmila M.   +5 more
core   +2 more sources

Revisiting the role of trimetazidine for peripheral artery disease: a systematic review with meta-analysis.

open access: yesJPMA. The Journal of the Pakistan Medical Association
OBJECTIVE To examine the impact of trimetazidine on skeletal muscle function in patients suffering from peripheral artery disease. METHODS The systematic review was conducted from July 20 to November 22, 2022, in line with the Preferred Reporting Items
R. Budiarto   +5 more
semanticscholar   +1 more source

Effectiveness of Proanthocyanidin plus Trimetazidine in the Treatment of Non-Small-Cell Lung Cancer with Radiation Heart Injury

open access: yesEvidence-Based Complementary and Alternative Medicine, 2022
This study was intended to explore the effect of proanthocyanidin (PC) combined with trimetazidine in non-small-cell lung cancer (NSCLC) with radiation-induced heart damage (RIHD).
H. Yin   +5 more
semanticscholar   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy

open access: yesFrontiers in Cardiovascular Medicine, 2022
Aims In-stent restenosis (ISR) is an unresolved problem following percutaneous coronary intervention (PCI), having a negative impact on clinical outcome.
Gábor Csató   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy